Optomed Oyj
OMXH:OPTOMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
FI |
|
B
|
Bion Environmental Technologies Inc
OTC:BNET
|
US |
|
R
|
Ratch Group PCL
SET:RATCH
|
TH |
Intrinsic Value
The intrinsic value of Optomed Oyj (OPTOMED) under the Base Case is 1.716 EUR per share. Compared with the current market price of 1.398 EUR, the stock appears Undervalued by 19% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -35% last year to -20% by 2031. If operating margin stayed at its five-year average of -34%, the estimate would be about €1.10. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Optomed Oyj Does
Optomed Oyj makes handheld fundus cameras and related software used to take pictures of the retina at the back of the eye. These devices help doctors, nurses, and screening programs spot eye disease and signs of conditions like diabetic retinopathy earlier, often outside a full ophthalmology clinic. The company sells its products to hospitals, eye clinics, primary care providers, and screening organizations, usually through direct sales and distribution partners.
- Headquarters
- Finland FI
- Employees
- 115
- IPO date
- Dec 9, 2019
Earnings Waterfall
Optomed Oyj
The intrinsic value for Optomed Oyj (OPTOMED) under the Base Case is 1.716 EUR.
Compared with the current market price of 1.398 EUR, the stock appears Undervalued by 19% .